ID   HS-PSS
AC   CVCL_8717
SY   Hs-PSS; HSPSS
DR   CLO; CLO_0051534
DR   BioSample; SAMN03471914
DR   DepMap; ACH-002065
DR   RCB; RCB2362
DR   Wikidata; Q54896288
RX   PubMed=28556483;
RX   PubMed=33707600;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=28556483; PubMed=33707600; RCB
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 14,15
ST   D19S433: 10.2,12,13 (PubMed=33707600)
ST   D19S433: 13 (PubMed=28556483)
ST   D21S11: 28,32
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 14,15 (PubMed=28556483)
ST   D8S1179: 14,15,19 (PubMed=33707600)
ST   FGA: 22
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=28556483; DOI=10.1002/1878-0261.12086;
RA   Kolberg M., Bruun J., Murumagi A., Mpindi J.P., Bergsland C.H.,
RA   Holand M., Eilertsen I.A., Danielsen S.A., Kallioniemi O.-P.,
RA   Lothe R.A.;
RT   "Drug sensitivity and resistance testing identifies PLK1 inhibitors
RT   and gemcitabine as potent drugs for malignant peripheral nerve sheath
RT   tumors.";
RL   Mol. Oncol. 11:1156-1171(2017).
//
RX   PubMed=33707600; DOI=10.1038/s41598-021-85055-2;
RA   Longo J.F., Brosius S.N., Znoyko I., Alers V.A., Jenkins D.P.,
RA   Wilson R.C., Carroll A.J. III, Wolff D.J., Roth K.A., Carroll S.L.;
RT   "Establishment and genomic characterization of a sporadic malignant
RT   peripheral nerve sheath tumor cell line.";
RL   Sci. Rep. 11:5690-5690(2021).
//